Web Content Management

PRODUCTS

  • Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.

  • Navigating the technical challenges of mAbs production and scalability

    Monoclonal antibodies (mAbs) offer promising immunotherapy treatments, targeting antigens and diseases. Manufacturing these complex therapies presents challenges in scaling up, cost, and consistency. Germfree’s expertise in tailored cleanroom solutions addresses these obstacles, ensuring sterility and seamless equipment integration. By providing advanced facilities for both small-scale clinical trials and larger-scale production, Germfree contributes to the successful development and commercialization of mAbs, ultimately improving patient outcomes and transforming healthcare landscapes.

  • Understanding the fine details of powder properties is crucial in the pharmaceutical industry, where the behavior of particulate matter can affect manufacturability and the efficacy of the final product.

  • Build cell-based models of disease and accelerate therapeutic development with TARGATT™ large knock-in technology in iPSCs.

  • Compliance solutions for product development agility and audit readiness.

WHITE PAPERS AND CASE STUDIES

NEWS